A number of analysts have recently weighed in on Advanced Micro Devices, Inc. (NYSE:AMD) shares. Analysts at Zacks downgraded shares of Advanced Micro Devices, Inc. (NYSE:AMD) from an “outperform” rating to a “neutral” rating in a research note on Wednesday, August 13th. They now have a $4.25 price target on the stock. Advanced Micro Devices, Inc. (NYSE:AMD) belongs to Technology sector. Its net profit margin is 1.40% and weekly performance is -0.24%. On last trading day company shares ended up $4.15. Advanced Micro Devices, Inc. (NYSE:AMD) distance from 50-day simple moving average (SMA50) is 0.69%.

Kinross Gold Corp. (NYSE:KGC) has taken some write-downs, as have Barrick and Newmont. With the exception of Goldcorp Inc. ($G:CA) (GG) , the list of majors doesn’t extend much beyond those names. It is generally understood that the major producers are focused on fixing internal problems, many of which were caused by aggressive M&A. Kinross Gold Corporation (NYSE:KGC) shares fell -2.36% in last trading session and ended the day at $3.73. KGC Gross Margin is 21.40% and its return on assets is -36.40%. Kinross Gold Corporation (NYSE:KGC) quarterly performance is -3.87%.

Symmetry Medical Inc. (NYSE:SMA) last announced its earnings results on Monday, August 4th. The company reported $0.17 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.12 by $0.05. The company had revenue of $101.30 million for the quarter, compared to the consensus estimate of $98.38 million. During the same quarter in the previous year, the company posted $0.09 earnings per share. The company’s revenue for the quarter was up 2.3% on a year-over-year basis. On average, analysts predict that Symmetry Medical will post $0.57 earnings per share for the current fiscal year. On 04 September, Symmetry Medical, Inc. (NYSE:SMA) shares fell -0.99% and was closed at $9.03. SMA EPS growth in last 5 year was -28.30%. Symmetry Medical, Inc. (NYSE:SMA) year to date (YTD) performance is -10.42%.

Paint and adhesive maker H.B. Fuller Co (NYSE:FUL) said Wednesday it has acquired ProSpec Construction Products, a provider of tile and stone installation products. The deal supports H.B. Fuller’s growth strategy by strengthening the company’s customer profile in the southeastern and western regions of the United States, where tile consumption is largest. HB Fuller Co. (NYSE:FUL) ended the last trading day at $46.64. Company weekly volatility is calculated as 1.62%and price to cash ratio as 24.66. HB Fuller Co. (NYSE:FUL) showed a weekly performance of -0.34%.

Edico Genome today announced that Sequenom, Inc. (NASDAQ:SQNM), a life sciences company that provides innovative genetic analysis solutions, purchased an Edico Genome DRAGEN Bio-IT Processor. The DRAGEN Bio-IT Processor is the world’s first next-generation sequencing bioinformatics application-specific integrated circuit (ASIC), which is embedded on a PCIe form factor card and accompanied with software as a Platform-as-a-Service (PaaS) platform. The two companies recently completed a proof-of-concept study, comparing results between Sequenom Laboratories’ (a wholly owned subsidiary of Sequenom, Inc.) current analysis pipeline and the results using DRAGEN. Sequenom Inc. (NASDAQ:SQNM) shares fell -1.07% in last trading session and ended the day on $3.69. SQNM Gross Margin is 41.50% and its return on assets is -41.30%. Sequenom Inc. (NASDAQ:SQNM) quarterly performance is 27.24%.